ARMP · Armata Pharmaceuticals Inc
United States · RS rating 13 · As of 2026-11-03
| Price | 3.09 USD |
|---|---|
| 1-day change | +8.4% |
| RS rating (overall / 1M / 3M / 12M) | 13 / 27 / 17 / 27 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 25 / 5 / 37 |
| Industry group (rank) | Medical-Generic Drugs (136) |
| EPS growth Q/Q | +91.5% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +79.1% |
| Market cap (USD) | $495.6M |